Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00684684
Other study ID # PRT01028
Secondary ID
Status Completed
Phase Phase 1
First received May 23, 2008
Last updated January 20, 2009
Start date May 2008
Est. completion date November 2008

Study information

Verified date January 2009
Source Pulmonx, Inc.
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments during bronchoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date November 2008
Est. primary completion date November 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Scheduled to undergo clinically indicated routine diagnostic bronchoscopy

Exclusion Criteria:

- Hyperexcretive chronic bronchitis or excessive sputum secretion

- Active pulmonary infection

- FEV1 <20% predicted

- FVC <50% predicted

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Chartis System
Assessment of airway flow and pressure

Locations

Country Name City State
Germany Thoraxklinik am Universitatsklinikum Heidelberg Heidelberg

Sponsors (1)

Lead Sponsor Collaborator
Pulmonx, Inc.

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse events Until discharge or 24 hours post procedure Yes
Secondary Technical success During procedure No
See also
  Status Clinical Trial Phase
Terminated NCT03581474 - Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting N/A
Completed NCT03294213 - Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
Completed NCT06116955 - The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
Withdrawn NCT03613792 - Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy Phase 4
Completed NCT04016480 - HFNC During Bronchoscopy for Bronchoalveolar Lavage N/A
Recruiting NCT01100554 - Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy N/A
Completed NCT00861835 - Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate (TBNA) N/A
Completed NCT05154916 - The Effect of Virtual Reality Based Relaxation Program on Patients to be Performed Bronchoscopy N/A
Completed NCT03086408 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy N/A
Active, not recruiting NCT04884061 - Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection
Completed NCT05875662 - Pulmonary Ventilation After Fiberoptic Bronchoscopy Using EIT
Completed NCT03521505 - Dexmedetomidine for Sedation of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Phase 4
Not yet recruiting NCT03856073 - The Training and Evaluate Effect on Clinical Airway Management for Novices. N/A
Not yet recruiting NCT03854760 - The Training and Evaluate Effect on Clinical Airway Management N/A
Recruiting NCT05912985 - Three Different Oxygenation Strategies in Bronchoscopy Procedures Under Sedation
Enrolling by invitation NCT05692362 - Measure Airway Compliance by Endobronchial Optical Coherence Tomography
Completed NCT03419546 - Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
Completed NCT03886454 - Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
Not yet recruiting NCT03983915 - Sedation Strategies for Therapeutic Bronchoscopy 2 N/A
Not yet recruiting NCT03983889 - Sedation Strategies for Diagnostic Bronchoscopy 2 N/A